TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA June 20, 1986